

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cysteine metabolic process (GO:0006534) | 4.56535878 |
| 2 | glycosphingolipid catabolic process (GO:0046479) | 4.39796517 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.38595740 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.38595740 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 4.38595740 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 4.38595740 |
| 7 | modulation by symbiont of host defense response (GO:0052031) | 4.38595740 |
| 8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.38595740 |
| 9 | low-density lipoprotein particle clearance (GO:0034383) | 4.18034634 |
| 10 | ceramide catabolic process (GO:0046514) | 4.10093772 |
| 11 | response to lipoprotein particle (GO:0055094) | 4.05121663 |
| 12 | glycolipid catabolic process (GO:0019377) | 3.98733367 |
| 13 | lysine metabolic process (GO:0006553) | 3.97568243 |
| 14 | lysine catabolic process (GO:0006554) | 3.97568243 |
| 15 | cellular response to ethanol (GO:0071361) | 3.93046866 |
| 16 | sphingoid metabolic process (GO:0046519) | 3.88172573 |
| 17 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.87825671 |
| 18 | oligosaccharide catabolic process (GO:0009313) | 3.87147512 |
| 19 | kynurenine metabolic process (GO:0070189) | 3.83936343 |
| 20 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.77242389 |
| 21 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.77131827 |
| 22 | sphingosine metabolic process (GO:0006670) | 3.76257959 |
| 23 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.74128091 |
| 24 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.73683976 |
| 25 | diol metabolic process (GO:0034311) | 3.73574138 |
| 26 | membrane lipid catabolic process (GO:0046466) | 3.68673478 |
| 27 | regulation of cholesterol storage (GO:0010885) | 3.60913613 |
| 28 | regulation of mononuclear cell migration (GO:0071675) | 3.58638526 |
| 29 | sphingolipid catabolic process (GO:0030149) | 3.52983843 |
| 30 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.52016980 |
| 31 | homocysteine metabolic process (GO:0050667) | 3.46641874 |
| 32 | positive regulation of heat generation (GO:0031652) | 3.44139136 |
| 33 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.39887294 |
| 34 | indole-containing compound catabolic process (GO:0042436) | 3.38651548 |
| 35 | indolalkylamine catabolic process (GO:0046218) | 3.38651548 |
| 36 | tryptophan catabolic process (GO:0006569) | 3.38651548 |
| 37 | macroautophagy (GO:0016236) | 3.38394259 |
| 38 | regulation of cholesterol homeostasis (GO:2000188) | 3.37108540 |
| 39 | positive regulation of interferon-alpha production (GO:0032727) | 3.36556387 |
| 40 | plasma lipoprotein particle clearance (GO:0034381) | 3.31398071 |
| 41 | urate metabolic process (GO:0046415) | 3.28750614 |
| 42 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.28082639 |
| 43 | osteoclast differentiation (GO:0030316) | 3.27523443 |
| 44 | sulfur amino acid catabolic process (GO:0000098) | 3.25593914 |
| 45 | regulation of chronic inflammatory response (GO:0002676) | 3.22689810 |
| 46 | apoptotic cell clearance (GO:0043277) | 3.22634518 |
| 47 | drug transmembrane transport (GO:0006855) | 3.18150555 |
| 48 | macrophage activation involved in immune response (GO:0002281) | 3.16534877 |
| 49 | regulation of interferon-alpha production (GO:0032647) | 3.16518102 |
| 50 | regulation of apoptotic cell clearance (GO:2000425) | 3.14766679 |
| 51 | import into cell (GO:0098657) | 3.12115369 |
| 52 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.11153434 |
| 53 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.10090494 |
| 54 | vitamin transmembrane transport (GO:0035461) | 3.05600184 |
| 55 | valine metabolic process (GO:0006573) | 2.96718960 |
| 56 | drug transport (GO:0015893) | 2.95266242 |
| 57 | detection of molecule of bacterial origin (GO:0032490) | 2.94748086 |
| 58 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.94419787 |
| 59 | response to thyroid hormone (GO:0097066) | 2.92075866 |
| 60 | adhesion of symbiont to host (GO:0044406) | 2.90582369 |
| 61 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.90539728 |
| 62 | regulation of immunoglobulin secretion (GO:0051023) | 2.90305896 |
| 63 | regulation of fever generation (GO:0031620) | 2.89954990 |
| 64 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.89908128 |
| 65 | alpha-linolenic acid metabolic process (GO:0036109) | 2.87619677 |
| 66 | amyloid precursor protein catabolic process (GO:0042987) | 2.87375600 |
| 67 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.85811241 |
| 68 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.84097434 |
| 69 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.83196447 |
| 70 | intestinal cholesterol absorption (GO:0030299) | 2.82804446 |
| 71 | negative regulation of lipid storage (GO:0010888) | 2.82534762 |
| 72 | negative regulation of complement activation (GO:0045916) | 2.81434935 |
| 73 | protein-lipid complex assembly (GO:0065005) | 2.77033489 |
| 74 | transepithelial transport (GO:0070633) | 2.74877492 |
| 75 | positive regulation of tissue remodeling (GO:0034105) | 2.74328270 |
| 76 | adhesion of symbiont to host cell (GO:0044650) | 2.73058576 |
| 77 | virion attachment to host cell (GO:0019062) | 2.73058576 |
| 78 | modified amino acid transport (GO:0072337) | 2.71942091 |
| 79 | plasma lipoprotein particle assembly (GO:0034377) | 2.70814014 |
| 80 | serine family amino acid catabolic process (GO:0009071) | 2.70767107 |
| 81 | negative regulation of protein activation cascade (GO:2000258) | 2.69759235 |
| 82 | regulation of vitamin metabolic process (GO:0030656) | 2.69174421 |
| 83 | amine catabolic process (GO:0009310) | 2.66812393 |
| 84 | cellular biogenic amine catabolic process (GO:0042402) | 2.66812393 |
| 85 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.66180037 |
| 86 | ganglioside metabolic process (GO:0001573) | 2.64796709 |
| 87 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.63945481 |
| 88 | keratan sulfate catabolic process (GO:0042340) | 2.63798463 |
| 89 | establishment of protein localization to vacuole (GO:0072666) | 2.63728750 |
| 90 | protein targeting to vacuole (GO:0006623) | 2.63728750 |
| 91 | protein targeting to lysosome (GO:0006622) | 2.63728750 |
| 92 | cell adhesion mediated by integrin (GO:0033627) | 2.62378398 |
| 93 | positive regulation of steroid biosynthetic process (GO:0010893) | 2.61347338 |
| 94 | response to host immune response (GO:0052572) | 2.61304858 |
| 95 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.61304858 |
| 96 | urea cycle (GO:0000050) | 2.61121063 |
| 97 | urea metabolic process (GO:0019627) | 2.61121063 |
| 98 | tryptophan metabolic process (GO:0006568) | 2.60515832 |
| 99 | toxin transport (GO:1901998) | 2.60109023 |
| 100 | response to peptidoglycan (GO:0032494) | 2.59392479 |
| 101 | positive regulation of interferon-beta production (GO:0032728) | 2.59211544 |
| 102 | serine family amino acid metabolic process (GO:0009069) | 2.59125416 |
| 103 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.59096334 |
| 104 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.58443523 |
| 105 | * iron ion import (GO:0097286) | 2.58044893 |
| 106 | pH reduction (GO:0045851) | 2.57693608 |
| 107 | cellular response to interferon-alpha (GO:0035457) | 2.57662435 |
| 108 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.57509231 |
| 109 | reverse cholesterol transport (GO:0043691) | 2.57422361 |
| 110 | positive regulation of bone remodeling (GO:0046852) | 2.56939492 |
| 111 | positive regulation of bone resorption (GO:0045780) | 2.56939492 |
| 112 | heme transport (GO:0015886) | 2.56677564 |
| 113 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.56487139 |
| 114 | cellular copper ion homeostasis (GO:0006878) | 2.56328066 |
| 115 | protein carboxylation (GO:0018214) | 2.56249421 |
| 116 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.56249421 |
| 117 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.56191513 |
| 118 | L-phenylalanine catabolic process (GO:0006559) | 2.56191513 |
| 119 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.56058651 |
| 120 | cholesterol efflux (GO:0033344) | 2.55933893 |
| 121 | positive regulation of lipid storage (GO:0010884) | 2.55595648 |
| 122 | glyoxylate metabolic process (GO:0046487) | 2.54512652 |
| 123 | positive regulation of cholesterol efflux (GO:0010875) | 2.53948451 |
| 124 | L-phenylalanine metabolic process (GO:0006558) | 2.53948367 |
| 125 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.53948367 |
| 126 | low-density lipoprotein particle remodeling (GO:0034374) | 2.53776211 |
| 127 | regulation of heat generation (GO:0031650) | 2.53395961 |
| 128 | cellular glucuronidation (GO:0052695) | 2.53323278 |
| 129 | I-kappaB phosphorylation (GO:0007252) | 2.52320754 |
| 130 | cellular modified amino acid catabolic process (GO:0042219) | 2.50980379 |
| 131 | regulation of early endosome to late endosome transport (GO:2000641) | 2.50776293 |
| 132 | intracellular pH reduction (GO:0051452) | 2.49798525 |
| 133 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.48986819 |
| 134 | positive regulation of osteoclast differentiation (GO:0045672) | 2.48746174 |
| 135 | regulation of triglyceride catabolic process (GO:0010896) | 2.48733997 |
| 136 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.48100314 |
| 137 | positive regulation of p38MAPK cascade (GO:1900745) | 2.47650184 |
| 138 | glucuronate metabolic process (GO:0019585) | 2.46140221 |
| 139 | uronic acid metabolic process (GO:0006063) | 2.46140221 |
| 140 | phospholipid homeostasis (GO:0055091) | 2.44989495 |
| 141 | tyrosine metabolic process (GO:0006570) | 2.44488234 |
| 142 | regulation of podosome assembly (GO:0071801) | 2.44050693 |
| 143 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.43348116 |
| 144 | response to host (GO:0075136) | 2.43348116 |
| 145 | response to host defenses (GO:0052200) | 2.43348116 |
| 146 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.40977233 |
| 147 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.40823512 |
| 148 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.40640689 |
| 149 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.40378600 |
| 150 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.40345977 |
| 151 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.40345977 |
| 152 | acute-phase response (GO:0006953) | 2.40153125 |
| 153 | ER overload response (GO:0006983) | 2.39879569 |
| 154 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.39812165 |
| 155 | amino-acid betaine metabolic process (GO:0006577) | 2.39504647 |
| 156 | modification by symbiont of host morphology or physiology (GO:0044003) | 2.39060949 |
| 157 | C4-dicarboxylate transport (GO:0015740) | 2.38715578 |
| 158 | N-acetylneuraminate metabolic process (GO:0006054) | 2.38665501 |
| 159 | cellular response to ATP (GO:0071318) | 2.38275099 |
| 160 | intestinal absorption (GO:0050892) | 2.37675713 |
| 161 | lipoprotein metabolic process (GO:0042157) | 2.37213905 |
| 162 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.36935666 |
| 163 | regulation of macrophage chemotaxis (GO:0010758) | 2.35492193 |
| 164 | regulation of vascular endothelial growth factor production (GO:0010574) | 2.32389463 |
| 165 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.30946802 |
| 166 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.30800576 |
| 167 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.30406311 |
| 168 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.29238001 |
| 169 | prostate gland growth (GO:0060736) | 2.27972721 |
| 170 | * iron ion transport (GO:0006826) | 2.27954269 |
| 171 | decidualization (GO:0046697) | 2.27846396 |
| 172 | phospholipid efflux (GO:0033700) | 2.27833584 |
| 173 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.25575606 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.48097563 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.04288712 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.72271719 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.47592598 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.19554268 |
| 6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.90027113 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.66015684 |
| 8 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.52596245 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.48460108 |
| 10 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.45007495 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.44133943 |
| 12 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.43823593 |
| 13 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.40594294 |
| 14 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.40186643 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.38880624 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 2.27311596 |
| 17 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.19787645 |
| 18 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.13208812 |
| 19 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.10251629 |
| 20 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.08292534 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.06658152 |
| 22 | AHR_22903824_ChIP-Seq_MCF-7_Human | 2.05105294 |
| 23 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.02101128 |
| 24 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 2.01451165 |
| 25 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.01241154 |
| 26 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.99793721 |
| 27 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.95385611 |
| 28 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.93318217 |
| 29 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.92395393 |
| 30 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.91292729 |
| 31 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.90156665 |
| 32 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.89666160 |
| 33 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.87904038 |
| 34 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.87823876 |
| 35 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.86591058 |
| 36 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.82356475 |
| 37 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.77534521 |
| 38 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.75464196 |
| 39 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.71840074 |
| 40 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.66267644 |
| 41 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.62153933 |
| 42 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.60479200 |
| 43 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.60466232 |
| 44 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.59428282 |
| 45 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.59402165 |
| 46 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.58569737 |
| 47 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.58371152 |
| 48 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.57765279 |
| 49 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.57444203 |
| 50 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.57197453 |
| 51 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.56908122 |
| 52 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.56445489 |
| 53 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.56095946 |
| 54 | GATA1_19941826_ChIP-Seq_K562_Human | 1.51441208 |
| 55 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.49934919 |
| 56 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.49933979 |
| 57 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.49769318 |
| 58 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.49762536 |
| 59 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.49088863 |
| 60 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.47607780 |
| 61 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.46261542 |
| 62 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.46028312 |
| 63 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.44279094 |
| 64 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.43791859 |
| 65 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.43778808 |
| 66 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.43686758 |
| 67 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.43151606 |
| 68 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.42992828 |
| 69 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.41320146 |
| 70 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.41313363 |
| 71 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.41205636 |
| 72 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.38587190 |
| 73 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.38218763 |
| 74 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.37815863 |
| 75 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.37318541 |
| 76 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.35268145 |
| 77 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.34491629 |
| 78 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.34099221 |
| 79 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.33842829 |
| 80 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.32610832 |
| 81 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.31911253 |
| 82 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.31797531 |
| 83 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.31549378 |
| 84 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.31092611 |
| 85 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.31063662 |
| 86 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30288481 |
| 87 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.28363723 |
| 88 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.28328551 |
| 89 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.28157105 |
| 90 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.27906646 |
| 91 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.27830026 |
| 92 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27608331 |
| 93 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.27404218 |
| 94 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.26831608 |
| 95 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.25926378 |
| 96 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.25868244 |
| 97 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.25830507 |
| 98 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.25640990 |
| 99 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.25353984 |
| 100 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.24891132 |
| 101 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.24526976 |
| 102 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.24349202 |
| 103 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.24348541 |
| 104 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.23353330 |
| 105 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.23258008 |
| 106 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.22983273 |
| 107 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.22684394 |
| 108 | GATA2_19941826_ChIP-Seq_K562_Human | 1.22551231 |
| 109 | P300_19829295_ChIP-Seq_ESCs_Human | 1.21639925 |
| 110 | TP53_16413492_ChIP-PET_HCT116_Human | 1.21626373 |
| 111 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.21577775 |
| 112 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.20587050 |
| 113 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.20036414 |
| 114 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.19349290 |
| 115 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.19053603 |
| 116 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.18978076 |
| 117 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.18712618 |
| 118 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.18319449 |
| 119 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.18247192 |
| 120 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.18222630 |
| 121 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.17710304 |
| 122 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.17106119 |
| 123 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.16355343 |
| 124 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.15441463 |
| 125 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.15247674 |
| 126 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.14876377 |
| 127 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.14803211 |
| 128 | CJUN_26792858_Chip-Seq_BT549_Human | 1.14750721 |
| 129 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.14445134 |
| 130 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.14014857 |
| 131 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.13867063 |
| 132 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.13354718 |
| 133 | TCF4_23295773_ChIP-Seq_U87_Human | 1.12687515 |
| 134 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12101646 |
| 135 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.12094731 |
| 136 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.11842669 |
| 137 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.10947319 |
| 138 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.10596250 |
| 139 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.07107230 |
| 140 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.05067572 |
| 141 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.04618963 |
| 142 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.03529281 |
| 143 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99592770 |
| 144 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.99490987 |
| 145 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.97086134 |
| 146 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.97024966 |
| 147 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.96986367 |
| 148 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.96798552 |
| 149 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.95884309 |
| 150 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.94849533 |
| 151 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.90842891 |
| 152 | * MAF_26560356_Chip-Seq_TH1_Human | 0.89897550 |
| 153 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89480472 |
| 154 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88197780 |
| 155 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.87929413 |
| 156 | * UTX_26944678_Chip-Seq_JUKART_Human | 0.86972656 |
| 157 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.86447805 |
| 158 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.86117682 |
| 159 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.86117682 |
| 160 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.85607643 |
| 161 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.85557173 |
| 162 | * MITF_21258399_ChIP-Seq_MELANOMA_Human | 0.85050672 |
| 163 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84389804 |
| 164 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.84312537 |
| 165 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.84312537 |
| 166 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.84263438 |
| 167 | KDM2B_26808549_Chip-Seq_K562_Human | 0.84209496 |
| 168 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.82744416 |
| 169 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.82409633 |
| 170 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.82163923 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 4.86668815 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.83126643 |
| 3 | MP0009840_abnormal_foam_cell | 3.46131049 |
| 4 | MP0005058_abnormal_lysosome_morphology | 3.43802068 |
| 5 | MP0003195_calcinosis | 3.03643234 |
| 6 | MP0005167_abnormal_blood-brain_barrier | 2.81739244 |
| 7 | MP0006054_spinal_hemorrhage | 2.81593001 |
| 8 | MP0005365_abnormal_bile_salt | 2.68808792 |
| 9 | * MP0003656_abnormal_erythrocyte_physiolo | 2.68331112 |
| 10 | MP0010678_abnormal_skin_adnexa | 2.61243701 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.59824617 |
| 12 | MP0000383_abnormal_hair_follicle | 2.50128454 |
| 13 | MP0006082_CNS_inflammation | 2.49673658 |
| 14 | MP0008875_abnormal_xenobiotic_pharmacok | 2.33886652 |
| 15 | MP0000604_amyloidosis | 2.28769430 |
| 16 | MP0005085_abnormal_gallbladder_physiolo | 2.23078078 |
| 17 | MP0003705_abnormal_hypodermis_morpholog | 2.22533443 |
| 18 | MP0005377_hearing/vestibular/ear_phenot | 2.19834176 |
| 19 | MP0003878_abnormal_ear_physiology | 2.19834176 |
| 20 | MP0000920_abnormal_myelination | 2.19277045 |
| 21 | MP0004947_skin_inflammation | 2.16549701 |
| 22 | MP0003252_abnormal_bile_duct | 2.16063596 |
| 23 | MP0005083_abnormal_biliary_tract | 2.10092903 |
| 24 | MP0005332_abnormal_amino_acid | 2.09659598 |
| 25 | MP0001666_abnormal_nutrient_absorption | 2.02571422 |
| 26 | MP0002148_abnormal_hypersensitivity_rea | 2.01262780 |
| 27 | MP0005257_abnormal_intraocular_pressure | 1.96079110 |
| 28 | MP0004264_abnormal_extraembryonic_tissu | 1.95177411 |
| 29 | MP0004233_abnormal_muscle_weight | 1.91624028 |
| 30 | MP0003300_gastrointestinal_ulcer | 1.84153737 |
| 31 | MP0003950_abnormal_plasma_membrane | 1.82255479 |
| 32 | MP0010329_abnormal_lipoprotein_level | 1.78803268 |
| 33 | MP0003172_abnormal_lysosome_physiology | 1.75749050 |
| 34 | MP0009278_abnormal_bone_marrow | 1.75400345 |
| 35 | MP0004019_abnormal_vitamin_homeostasis | 1.70447040 |
| 36 | * MP0000609_abnormal_liver_physiology | 1.62784606 |
| 37 | MP0004782_abnormal_surfactant_physiolog | 1.57387375 |
| 38 | MP0001853_heart_inflammation | 1.55524959 |
| 39 | MP0003303_peritoneal_inflammation | 1.54464393 |
| 40 | MP0003632_abnormal_nervous_system | 1.53672983 |
| 41 | MP0004043_abnormal_pH_regulation | 1.48318847 |
| 42 | MP0008438_abnormal_cutaneous_collagen | 1.46442097 |
| 43 | MP0003436_decreased_susceptibility_to | 1.45617048 |
| 44 | MP0009764_decreased_sensitivity_to | 1.42751154 |
| 45 | MP0009643_abnormal_urine_homeostasis | 1.41803520 |
| 46 | MP0001501_abnormal_sleep_pattern | 1.40478570 |
| 47 | MP0010234_abnormal_vibrissa_follicle | 1.38883383 |
| 48 | MP0005319_abnormal_enzyme/_coenzyme | 1.38694495 |
| 49 | MP0003806_abnormal_nucleotide_metabolis | 1.37797251 |
| 50 | MP0003329_amyloid_beta_deposits | 1.37123390 |
| 51 | MP0000647_abnormal_sebaceous_gland | 1.35673640 |
| 52 | MP0002877_abnormal_melanocyte_morpholog | 1.35336879 |
| 53 | MP0009785_altered_susceptibility_to | 1.34848863 |
| 54 | MP0001756_abnormal_urination | 1.33024712 |
| 55 | MP0005076_abnormal_cell_differentiation | 1.32251376 |
| 56 | MP0003453_abnormal_keratinocyte_physiol | 1.32131644 |
| 57 | MP0003690_abnormal_glial_cell | 1.31935395 |
| 58 | MP0005397_hematopoietic_system_phenotyp | 1.31354841 |
| 59 | MP0001545_abnormal_hematopoietic_system | 1.31354841 |
| 60 | MP0002098_abnormal_vibrissa_morphology | 1.31275877 |
| 61 | MP0005408_hypopigmentation | 1.31204412 |
| 62 | MP0000371_diluted_coat_color | 1.30783828 |
| 63 | MP0000569_abnormal_digit_pigmentation | 1.30238408 |
| 64 | MP0008469_abnormal_protein_level | 1.27479303 |
| 65 | MP0002118_abnormal_lipid_homeostasis | 1.27476307 |
| 66 | MP0005451_abnormal_body_composition | 1.22046185 |
| 67 | MP0004858_abnormal_nervous_system | 1.21699020 |
| 68 | MP0010307_abnormal_tumor_latency | 1.21445399 |
| 69 | MP0002138_abnormal_hepatobiliary_system | 1.20171064 |
| 70 | MP0001533_abnormal_skeleton_physiology | 1.20166837 |
| 71 | MP0003634_abnormal_glial_cell | 1.19164816 |
| 72 | MP0001958_emphysema | 1.18782842 |
| 73 | MP0003075_altered_response_to | 1.18649282 |
| 74 | MP0003045_fibrosis | 1.17801668 |
| 75 | MP0001984_abnormal_olfaction | 1.17794852 |
| 76 | MP0005646_abnormal_pituitary_gland | 1.17423187 |
| 77 | MP0002419_abnormal_innate_immunity | 1.17310879 |
| 78 | MP0005248_abnormal_Harderian_gland | 1.16448070 |
| 79 | MP0003941_abnormal_skin_development | 1.16307748 |
| 80 | MP0001324_abnormal_eye_pigmentation | 1.14450375 |
| 81 | MP0002998_abnormal_bone_remodeling | 1.12694863 |
| 82 | MP0009780_abnormal_chondrocyte_physiolo | 1.11350681 |
| 83 | MP0008004_abnormal_stomach_pH | 1.10735313 |
| 84 | MP0002653_abnormal_ependyma_morphology | 1.09318391 |
| 85 | MP0002136_abnormal_kidney_physiology | 1.08569687 |
| 86 | MP0002229_neurodegeneration | 1.07238446 |
| 87 | MP0005023_abnormal_wound_healing | 1.06110374 |
| 88 | MP0003633_abnormal_nervous_system | 1.05830705 |
| 89 | MP0005166_decreased_susceptibility_to | 1.03763518 |
| 90 | MP0002168_other_aberrant_phenotype | 1.02310785 |
| 91 | MP0003186_abnormal_redox_activity | 1.01927272 |
| 92 | MP0003631_nervous_system_phenotype | 1.01527703 |
| 93 | MP0005310_abnormal_salivary_gland | 1.01064872 |
| 94 | MP0003646_muscle_fatigue | 0.99670960 |
| 95 | MP0008260_abnormal_autophagy | 0.99382993 |
| 96 | * MP0005636_abnormal_mineral_homeostasis | 0.98811975 |
| 97 | MP0000598_abnormal_liver_morphology | 0.95899678 |
| 98 | MP0003890_abnormal_embryonic-extraembry | 0.94828616 |
| 99 | MP0000427_abnormal_hair_cycle | 0.94463834 |
| 100 | MP0005464_abnormal_platelet_physiology | 0.93498598 |
| 101 | MP0005025_abnormal_response_to | 0.92968865 |
| 102 | MP0004510_myositis | 0.92789180 |
| 103 | MP0002896_abnormal_bone_mineralization | 0.89549257 |
| 104 | MP0001727_abnormal_embryo_implantation | 0.88712231 |
| 105 | MP0003879_abnormal_hair_cell | 0.87907384 |
| 106 | MP0003091_abnormal_cell_migration | 0.87757175 |
| 107 | MP0001845_abnormal_inflammatory_respons | 0.87338100 |
| 108 | MP0003566_abnormal_cell_adhesion | 0.86845227 |
| 109 | MP0001919_abnormal_reproductive_system | 0.85803207 |
| 110 | MP0000685_abnormal_immune_system | 0.85512989 |
| 111 | MP0003724_increased_susceptibility_to | 0.84349273 |
| 112 | MP0010352_gastrointestinal_tract_polyps | 0.83559000 |
| 113 | MP0003448_altered_tumor_morphology | 0.81020389 |
| 114 | MP0004185_abnormal_adipocyte_glucose | 0.80775354 |
| 115 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.80608335 |
| 116 | MP0001790_abnormal_immune_system | 0.80250303 |
| 117 | MP0005387_immune_system_phenotype | 0.80250303 |
| 118 | MP0005253_abnormal_eye_physiology | 0.80234456 |
| 119 | MP0009046_muscle_twitch | 0.79445983 |
| 120 | MP0002090_abnormal_vision | 0.78337396 |
| 121 | MP0001216_abnormal_epidermal_layer | 0.74928818 |
| 122 | MP0002295_abnormal_pulmonary_circulatio | 0.74355729 |
| 123 | MP0009333_abnormal_splenocyte_physiolog | 0.71808969 |
| 124 | MP0005647_abnormal_sex_gland | 0.71693071 |
| 125 | MP0001191_abnormal_skin_condition | 0.71284688 |
| 126 | MP0010155_abnormal_intestine_physiology | 0.70983672 |
| 127 | MP0004130_abnormal_muscle_cell | 0.70711430 |
| 128 | MP0001765_abnormal_ion_homeostasis | 0.70612649 |
| 129 | MP0001849_ear_inflammation | 0.70605648 |
| 130 | MP0003868_abnormal_feces_composition | 0.70488820 |
| 131 | * MP0005395_other_phenotype | 0.70053540 |
| 132 | MP0009763_increased_sensitivity_to | 0.69523607 |
| 133 | MP0005164_abnormal_response_to | 0.69190629 |
| 134 | MP0002332_abnormal_exercise_endurance | 0.68974739 |
| 135 | MP0000733_abnormal_muscle_development | 0.68372176 |
| 136 | MP0000343_altered_response_to | 0.67260940 |
| 137 | MP0005551_abnormal_eye_electrophysiolog | 0.66239448 |
| 138 | MP0000858_altered_metastatic_potential | 0.66230938 |
| 139 | MP0005000_abnormal_immune_tolerance | 0.65851117 |
| 140 | MP0000377_abnormal_hair_follicle | 0.65150885 |
| 141 | MP0005171_absent_coat_pigmentation | 0.64908133 |
| 142 | MP0000627_abnormal_mammary_gland | 0.63938896 |
| 143 | MP0004885_abnormal_endolymph | 0.63317505 |
| 144 | MP0002254_reproductive_system_inflammat | 0.63001792 |
| 145 | MP0002796_impaired_skin_barrier | 0.62272226 |
| 146 | MP0001881_abnormal_mammary_gland | 0.62005340 |
| 147 | MP0001243_abnormal_dermal_layer | 0.61834804 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Neurofibrillary tangles (HP:0002185) | 5.01019074 |
| 2 | Glomerulonephritis (HP:0000099) | 4.28946910 |
| 3 | Disinhibition (HP:0000734) | 4.08877991 |
| 4 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.73375489 |
| 5 | Increased cerebral lipofuscin (HP:0011813) | 3.62139188 |
| 6 | Abnormality of proline metabolism (HP:0010907) | 3.52474930 |
| 7 | Hydroxyprolinuria (HP:0003080) | 3.52474930 |
| 8 | Myocardial infarction (HP:0001658) | 3.21359000 |
| 9 | Cerebral inclusion bodies (HP:0100314) | 3.14047633 |
| 10 | Deep venous thrombosis (HP:0002625) | 3.09613163 |
| 11 | Mutism (HP:0002300) | 3.09105112 |
| 12 | Autoimmune thrombocytopenia (HP:0001973) | 3.07941443 |
| 13 | Systemic lupus erythematosus (HP:0002725) | 3.07797994 |
| 14 | Agnosia (HP:0010524) | 3.06954976 |
| 15 | Gout (HP:0001997) | 3.05584314 |
| 16 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.01311821 |
| 17 | Hyperglycinuria (HP:0003108) | 2.99939258 |
| 18 | Pustule (HP:0200039) | 2.97305590 |
| 19 | Xanthomatosis (HP:0000991) | 2.95858352 |
| 20 | Dysostosis multiplex (HP:0000943) | 2.91889965 |
| 21 | Vacuolated lymphocytes (HP:0001922) | 2.91622978 |
| 22 | Reticulocytosis (HP:0001923) | 2.90363140 |
| 23 | Osteolytic defects of the hand bones (HP:0009699) | 2.88195816 |
| 24 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.88195816 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 2.84187425 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.84187425 |
| 27 | Premature rupture of membranes (HP:0001788) | 2.80256996 |
| 28 | Hyperglycinemia (HP:0002154) | 2.79242664 |
| 29 | Nuclear cataract (HP:0100018) | 2.77559267 |
| 30 | Retinal atrophy (HP:0001105) | 2.76810671 |
| 31 | Intrahepatic cholestasis (HP:0001406) | 2.75170874 |
| 32 | Complement deficiency (HP:0004431) | 2.74895385 |
| 33 | Nausea (HP:0002018) | 2.74092104 |
| 34 | Inappropriate behavior (HP:0000719) | 2.70090754 |
| 35 | Abnormality of purine metabolism (HP:0004352) | 2.68167695 |
| 36 | Global brain atrophy (HP:0002283) | 2.65902732 |
| 37 | Apathy (HP:0000741) | 2.65382555 |
| 38 | Neuronal loss in central nervous system (HP:0002529) | 2.61904676 |
| 39 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.61188955 |
| 40 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.60202678 |
| 41 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.59122008 |
| 42 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.59122008 |
| 43 | Abnormality of glycolipid metabolism (HP:0010969) | 2.59122008 |
| 44 | Acanthocytosis (HP:0001927) | 2.58465929 |
| 45 | Poikilocytosis (HP:0004447) | 2.58046788 |
| 46 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.56225979 |
| 47 | Mucopolysacchariduria (HP:0008155) | 2.56225979 |
| 48 | Personality changes (HP:0000751) | 2.55022846 |
| 49 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.52479300 |
| 50 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.51346569 |
| 51 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.51346569 |
| 52 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.51346569 |
| 53 | Diminished motivation (HP:0000745) | 2.51203348 |
| 54 | Ulnar bowing (HP:0003031) | 2.49412941 |
| 55 | Ileus (HP:0002595) | 2.46437539 |
| 56 | Metaphyseal irregularity (HP:0003025) | 2.45611791 |
| 57 | Vascular calcification (HP:0004934) | 2.43835949 |
| 58 | Cupped ribs (HP:0000887) | 2.42492090 |
| 59 | Fat malabsorption (HP:0002630) | 2.41461703 |
| 60 | Axonal loss (HP:0003447) | 2.41314791 |
| 61 | Abnormality of complement system (HP:0005339) | 2.37254158 |
| 62 | Tetraparesis (HP:0002273) | 2.35950580 |
| 63 | Cardiovascular calcification (HP:0011915) | 2.34355299 |
| 64 | Abnormality of the periventricular white matter (HP:0002518) | 2.31813470 |
| 65 | Alopecia of scalp (HP:0002293) | 2.31582854 |
| 66 | Vertebral compression fractures (HP:0002953) | 2.31151419 |
| 67 | Increased serum ferritin (HP:0003281) | 2.30826162 |
| 68 | Metaphyseal cupping (HP:0003021) | 2.30787970 |
| 69 | Polycythemia (HP:0001901) | 2.29818638 |
| 70 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.28672268 |
| 71 | Abnormality of macrophages (HP:0004311) | 2.27576069 |
| 72 | Spastic tetraparesis (HP:0001285) | 2.24186844 |
| 73 | Curly hair (HP:0002212) | 2.24016585 |
| 74 | Turricephaly (HP:0000262) | 2.22228399 |
| 75 | Thick nail (HP:0001805) | 2.20239915 |
| 76 | Hyperammonemia (HP:0001987) | 2.18055100 |
| 77 | Abnormality of iron homeostasis (HP:0011031) | 2.15670527 |
| 78 | Hypoalphalipoproteinemia (HP:0003233) | 2.15581002 |
| 79 | Mitral stenosis (HP:0001718) | 2.15379279 |
| 80 | Hematochezia (HP:0002573) | 2.15356365 |
| 81 | Abnormality of the common coagulation pathway (HP:0010990) | 2.13061162 |
| 82 | Abnormality of nucleobase metabolism (HP:0010932) | 2.11711894 |
| 83 | Cardiomegaly (HP:0001640) | 2.10470478 |
| 84 | Esophageal varix (HP:0002040) | 2.10246017 |
| 85 | Hand muscle atrophy (HP:0009130) | 2.10210609 |
| 86 | Flat acetabular roof (HP:0003180) | 2.10041024 |
| 87 | Spastic diplegia (HP:0001264) | 2.09864803 |
| 88 | Steatorrhea (HP:0002570) | 2.05670843 |
| 89 | Hepatocellular carcinoma (HP:0001402) | 2.04916030 |
| 90 | Pathologic fracture (HP:0002756) | 2.04896504 |
| 91 | Sensorimotor neuropathy (HP:0007141) | 2.04614134 |
| 92 | Hypolipoproteinemia (HP:0010981) | 2.03044176 |
| 93 | Hypobetalipoproteinemia (HP:0003563) | 2.01357463 |
| 94 | Malnutrition (HP:0004395) | 2.00391841 |
| 95 | Amyloidosis (HP:0011034) | 2.00313231 |
| 96 | Progressive visual loss (HP:0000529) | 1.99018703 |
| 97 | Hypothermia (HP:0002045) | 1.98097589 |
| 98 | Abnormality of the Achilles tendon (HP:0005109) | 1.95460986 |
| 99 | Hyperventilation (HP:0002883) | 1.95050567 |
| 100 | Male infertility (HP:0003251) | 1.93738802 |
| 101 | Papillary thyroid carcinoma (HP:0002895) | 1.93645788 |
| 102 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.93127084 |
| 103 | Protuberant abdomen (HP:0001538) | 1.93079555 |
| 104 | Increased CSF protein (HP:0002922) | 1.92941042 |
| 105 | Pheochromocytoma (HP:0002666) | 1.92483038 |
| 106 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.92390354 |
| 107 | Cerebellar dysplasia (HP:0007033) | 1.90688690 |
| 108 | Cholelithiasis (HP:0001081) | 1.90582669 |
| 109 | Ketosis (HP:0001946) | 1.90173197 |
| 110 | Tubulointerstitial fibrosis (HP:0005576) | 1.89785898 |
| 111 | Paraparesis (HP:0002385) | 1.89060281 |
| 112 | Distal upper limb amyotrophy (HP:0007149) | 1.88948848 |
| 113 | Upper limb amyotrophy (HP:0009129) | 1.88948848 |
| 114 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.87730991 |
| 115 | Cholecystitis (HP:0001082) | 1.87259894 |
| 116 | Abnormal gallbladder physiology (HP:0012438) | 1.87259894 |
| 117 | Skin nodule (HP:0200036) | 1.85718379 |
| 118 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.84369509 |
| 119 | Increased purine levels (HP:0004368) | 1.83949316 |
| 120 | Hyperuricemia (HP:0002149) | 1.83949316 |
| 121 | Nephritis (HP:0000123) | 1.83256749 |
| 122 | Interstitial pulmonary disease (HP:0006530) | 1.81625133 |
| 123 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.81611558 |
| 124 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.79970385 |
| 125 | Loss of speech (HP:0002371) | 1.79543002 |
| 126 | Abnormality of the nasal septum (HP:0000419) | 1.79114279 |
| 127 | Optic neuritis (HP:0100653) | 1.78249359 |
| 128 | Retrobulbar optic neuritis (HP:0100654) | 1.78249359 |
| 129 | Abnormal cartilage morphology (HP:0002763) | 1.76805764 |
| 130 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.76495411 |
| 131 | Cortical dysplasia (HP:0002539) | 1.73785857 |
| 132 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.73213941 |
| 133 | Hyperlipoproteinemia (HP:0010980) | 1.72580864 |
| 134 | Peripheral demyelination (HP:0011096) | 1.72561005 |
| 135 | Albinism (HP:0001022) | 1.70194921 |
| 136 | Spastic paraplegia (HP:0001258) | 1.69484610 |
| 137 | Dementia (HP:0000726) | 1.69160350 |
| 138 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.68395770 |
| 139 | Lower limb hyperreflexia (HP:0002395) | 1.67767891 |
| 140 | Urinary incontinence (HP:0000020) | 1.67127605 |
| 141 | Abnormality of the lumbar spine (HP:0100712) | 1.62583663 |
| 142 | Epidermoid cyst (HP:0200040) | 1.61660919 |
| 143 | Prolonged neonatal jaundice (HP:0006579) | 1.61168072 |
| 144 | Blue irides (HP:0000635) | 1.56014383 |
| 145 | Symptomatic seizures (HP:0011145) | 1.53808283 |
| 146 | Supranuclear gaze palsy (HP:0000605) | 1.52894103 |
| 147 | Abnormality of the axillary hair (HP:0100134) | 1.51743863 |
| 148 | Abnormality of secondary sexual hair (HP:0009888) | 1.51743863 |
| 149 | Ascites (HP:0001541) | 1.51532009 |
| 150 | Pseudobulbar signs (HP:0002200) | 1.50561925 |
| 151 | Congenital primary aphakia (HP:0007707) | 1.48814371 |
| 152 | Biliary tract neoplasm (HP:0100574) | 1.48578040 |
| 153 | Paraplegia (HP:0010550) | 1.48333686 |
| 154 | Nephrogenic diabetes insipidus (HP:0009806) | 1.48217655 |
| 155 | Portal hypertension (HP:0001409) | 1.47991678 |
| 156 | Hyperaldosteronism (HP:0000859) | 1.47466434 |
| 157 | Thyroid carcinoma (HP:0002890) | 1.46840624 |
| 158 | Gait imbalance (HP:0002141) | 1.44850874 |
| 159 | Autoamputation (HP:0001218) | 1.41299428 |
| 160 | Dysdiadochokinesis (HP:0002075) | 1.39520332 |
| 161 | Hammertoe (HP:0001765) | 1.38898280 |
| 162 | Genetic anticipation (HP:0003743) | 1.36938159 |
| 163 | Action tremor (HP:0002345) | 1.36856271 |
| 164 | Beaking of vertebral bodies (HP:0004568) | 1.34826992 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.22890737 |
| 2 | TRIB3 | 3.30975968 |
| 3 | ACVR1B | 2.97934325 |
| 4 | TBK1 | 2.91370195 |
| 5 | LATS1 | 2.77290498 |
| 6 | MST1R | 2.68477650 |
| 7 | EIF2AK3 | 2.65391181 |
| 8 | SIK1 | 2.43374168 |
| 9 | MATK | 2.40395633 |
| 10 | PBK | 2.30028620 |
| 11 | TYK2 | 2.27795257 |
| 12 | GRK7 | 2.21364651 |
| 13 | FGFR4 | 2.18077400 |
| 14 | BMX | 2.10441488 |
| 15 | STK3 | 1.94157655 |
| 16 | IRAK3 | 1.93225896 |
| 17 | PKN2 | 1.92862062 |
| 18 | MAP3K10 | 1.86704502 |
| 19 | TAOK3 | 1.85392820 |
| 20 | IKBKE | 1.85208077 |
| 21 | JAK1 | 1.82816107 |
| 22 | CASK | 1.76026410 |
| 23 | DDR2 | 1.75255250 |
| 24 | ADRBK2 | 1.74110039 |
| 25 | AKT3 | 1.73356850 |
| 26 | TGFBR2 | 1.69306764 |
| 27 | PTK6 | 1.68429485 |
| 28 | EPHB1 | 1.68068436 |
| 29 | NEK6 | 1.67721849 |
| 30 | ICK | 1.65599017 |
| 31 | STK38L | 1.62039015 |
| 32 | MET | 1.59258942 |
| 33 | FER | 1.57622601 |
| 34 | TAOK1 | 1.56750314 |
| 35 | BMPR2 | 1.54362261 |
| 36 | TSSK6 | 1.52706299 |
| 37 | EPHA2 | 1.47575307 |
| 38 | STK10 | 1.44669237 |
| 39 | CDK12 | 1.40296590 |
| 40 | RIPK4 | 1.35930752 |
| 41 | TTN | 1.33818816 |
| 42 | CDC42BPA | 1.31201996 |
| 43 | PDGFRA | 1.19522305 |
| 44 | MAP3K14 | 1.15958746 |
| 45 | JAK2 | 1.15623522 |
| 46 | BCKDK | 1.15532051 |
| 47 | CAMK1D | 1.14705869 |
| 48 | OXSR1 | 1.12405970 |
| 49 | RIPK1 | 1.10733219 |
| 50 | JAK3 | 1.09968534 |
| 51 | DAPK2 | 1.08976894 |
| 52 | BCR | 1.07720701 |
| 53 | ERBB4 | 1.07505210 |
| 54 | CAMKK2 | 1.05884225 |
| 55 | FGFR2 | 1.04617868 |
| 56 | MAP3K11 | 0.99803543 |
| 57 | CDK6 | 0.98749336 |
| 58 | MAP3K13 | 0.98614122 |
| 59 | MTOR | 0.98597206 |
| 60 | MAPK11 | 0.98467518 |
| 61 | BLK | 0.97796525 |
| 62 | PIK3CA | 0.96505513 |
| 63 | BRSK2 | 0.96028394 |
| 64 | ZAP70 | 0.95114252 |
| 65 | WNK4 | 0.94922439 |
| 66 | FGR | 0.92732215 |
| 67 | NTRK3 | 0.91844647 |
| 68 | MARK3 | 0.91370551 |
| 69 | PDGFRB | 0.90838354 |
| 70 | SIK3 | 0.90289276 |
| 71 | MAP3K3 | 0.89579797 |
| 72 | PDPK1 | 0.86790636 |
| 73 | CSK | 0.80535797 |
| 74 | FGFR1 | 0.80097412 |
| 75 | EPHA4 | 0.79717487 |
| 76 | IKBKB | 0.79206265 |
| 77 | STK4 | 0.78982894 |
| 78 | TYRO3 | 0.78526848 |
| 79 | TNIK | 0.77155482 |
| 80 | TRIM28 | 0.72335683 |
| 81 | ERBB3 | 0.72289454 |
| 82 | PLK2 | 0.71400450 |
| 83 | YES1 | 0.70973675 |
| 84 | NUAK1 | 0.70603075 |
| 85 | RPS6KA4 | 0.68917496 |
| 86 | BMPR1B | 0.68454505 |
| 87 | CDK4 | 0.67158308 |
| 88 | ABL2 | 0.66594134 |
| 89 | LRRK2 | 0.66523564 |
| 90 | PRKAA1 | 0.65083841 |
| 91 | MKNK1 | 0.64805134 |
| 92 | STK38 | 0.64712454 |
| 93 | TGFBR1 | 0.63770412 |
| 94 | RPS6KB1 | 0.62284384 |
| 95 | MAP3K8 | 0.61773376 |
| 96 | ERBB2 | 0.61755475 |
| 97 | STK39 | 0.61206487 |
| 98 | MAP2K3 | 0.58971059 |
| 99 | FRK | 0.57716953 |
| 100 | SGK3 | 0.57299842 |
| 101 | EGFR | 0.57173050 |
| 102 | WNK1 | 0.57143633 |
| 103 | SIK2 | 0.56785297 |
| 104 | CAMK1G | 0.56725481 |
| 105 | CSNK1A1L | 0.56381652 |
| 106 | NEK9 | 0.56308032 |
| 107 | TRPM7 | 0.55563927 |
| 108 | WNK3 | 0.55362741 |
| 109 | PDK2 | 0.55167823 |
| 110 | FGFR3 | 0.54355096 |
| 111 | PAK4 | 0.53928894 |
| 112 | MST4 | 0.53463229 |
| 113 | KSR1 | 0.51992988 |
| 114 | CHUK | 0.51963258 |
| 115 | PRKCE | 0.50540813 |
| 116 | BRD4 | 0.50487550 |
| 117 | MAP2K6 | 0.49616137 |
| 118 | PTK2 | 0.49405883 |
| 119 | ALK | 0.49294448 |
| 120 | GSK3A | 0.48083798 |
| 121 | INSRR | 0.47206472 |
| 122 | MAP3K5 | 0.47129967 |
| 123 | NME2 | 0.46932864 |
| 124 | ABL1 | 0.45557217 |
| 125 | PRKCH | 0.45465933 |
| 126 | MAP3K9 | 0.44349942 |
| 127 | PDK1 | 0.44032202 |
| 128 | TTK | 0.43408600 |
| 129 | SGK2 | 0.42949685 |
| 130 | MAP3K2 | 0.42731532 |
| 131 | NEK1 | 0.42535982 |
| 132 | NEK2 | 0.42394086 |
| 133 | SGK1 | 0.42376917 |
| 134 | KSR2 | 0.41031253 |
| 135 | FYN | 0.40905615 |
| 136 | MAP3K7 | 0.40896303 |
| 137 | MAP4K1 | 0.38877023 |
| 138 | PRKAA2 | 0.37727479 |
| 139 | EEF2K | 0.37468381 |
| 140 | MAPK10 | 0.36996902 |
| 141 | MELK | 0.36890380 |
| 142 | INSR | 0.36829239 |
| 143 | PIM2 | 0.35287146 |
| 144 | EIF2AK1 | 0.33312589 |
| 145 | LATS2 | 0.32512681 |
| 146 | PAK2 | 0.32318859 |
| 147 | CSNK1E | 0.31985077 |
| 148 | CSNK1A1 | 0.31831902 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.58026630 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.28712603 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.23996188 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.14959477 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.13544283 |
| 6 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.99661029 |
| 7 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.97266351 |
| 8 | * Lysosome_Homo sapiens_hsa04142 | 1.94868832 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.92413799 |
| 10 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.82537366 |
| 11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.72361251 |
| 12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.71181841 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.71023438 |
| 14 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.70944777 |
| 15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.70926836 |
| 16 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.66431254 |
| 17 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.64793902 |
| 18 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.62121576 |
| 19 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.52810518 |
| 20 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.44530429 |
| 21 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.44316594 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.42352728 |
| 23 | Bile secretion_Homo sapiens_hsa04976 | 1.40663497 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.37743754 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.37480989 |
| 26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.35540621 |
| 27 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.34240217 |
| 28 | * Mineral absorption_Homo sapiens_hsa04978 | 1.32966427 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.32261813 |
| 30 | Circadian rhythm_Homo sapiens_hsa04710 | 1.27365786 |
| 31 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.25768203 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.24128608 |
| 33 | Malaria_Homo sapiens_hsa05144 | 1.17709169 |
| 34 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.17494239 |
| 35 | Legionellosis_Homo sapiens_hsa05134 | 1.15854200 |
| 36 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.12904474 |
| 37 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.11443470 |
| 38 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.11073224 |
| 39 | ABC transporters_Homo sapiens_hsa02010 | 1.09650800 |
| 40 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.08279672 |
| 41 | Sulfur relay system_Homo sapiens_hsa04122 | 1.08136190 |
| 42 | Peroxisome_Homo sapiens_hsa04146 | 1.05814792 |
| 43 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.05683309 |
| 44 | Leishmaniasis_Homo sapiens_hsa05140 | 1.04748056 |
| 45 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.04699046 |
| 46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.04336571 |
| 47 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.03230050 |
| 48 | Tuberculosis_Homo sapiens_hsa05152 | 1.03042098 |
| 49 | Influenza A_Homo sapiens_hsa05164 | 1.02001561 |
| 50 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.00934671 |
| 51 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.00517415 |
| 52 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.00154216 |
| 53 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.00130189 |
| 54 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.95135518 |
| 55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.93308321 |
| 56 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.92646109 |
| 57 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.92236193 |
| 58 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.91992195 |
| 59 | Hepatitis C_Homo sapiens_hsa05160 | 0.91748829 |
| 60 | Prion diseases_Homo sapiens_hsa05020 | 0.91443747 |
| 61 | Amoebiasis_Homo sapiens_hsa05146 | 0.89480783 |
| 62 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.88743162 |
| 63 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.86616226 |
| 64 | Bladder cancer_Homo sapiens_hsa05219 | 0.86167369 |
| 65 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.85372632 |
| 66 | Measles_Homo sapiens_hsa05162 | 0.84393948 |
| 67 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.84255679 |
| 68 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.82177830 |
| 69 | Lysine degradation_Homo sapiens_hsa00310 | 0.82139376 |
| 70 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.80215475 |
| 71 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.79624085 |
| 72 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.79338392 |
| 73 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.78941217 |
| 74 | Pertussis_Homo sapiens_hsa05133 | 0.78332644 |
| 75 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.74721560 |
| 76 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.74407769 |
| 77 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.74124174 |
| 78 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.74102625 |
| 79 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.74077149 |
| 80 | Insulin resistance_Homo sapiens_hsa04931 | 0.73002171 |
| 81 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.72674594 |
| 82 | Carbon metabolism_Homo sapiens_hsa01200 | 0.72150544 |
| 83 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.71402336 |
| 84 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.70256170 |
| 85 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.68302366 |
| 86 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.64770189 |
| 87 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.64417745 |
| 88 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.64001591 |
| 89 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.62964016 |
| 90 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.61578782 |
| 91 | Retinol metabolism_Homo sapiens_hsa00830 | 0.61523825 |
| 92 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.61519592 |
| 93 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.60913840 |
| 94 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.60408123 |
| 95 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.59511644 |
| 96 | Other glycan degradation_Homo sapiens_hsa00511 | 0.58858446 |
| 97 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.58470038 |
| 98 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.57949139 |
| 99 | Apoptosis_Homo sapiens_hsa04210 | 0.56639437 |
| 100 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.56072098 |
| 101 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.56000557 |
| 102 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.55677285 |
| 103 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.55597928 |
| 104 | Salmonella infection_Homo sapiens_hsa05132 | 0.55357635 |
| 105 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.54159567 |
| 106 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.53312529 |
| 107 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.53199551 |
| 108 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.53194938 |
| 109 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.53060610 |
| 110 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.52967258 |
| 111 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.51610294 |
| 112 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.49727400 |
| 113 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.48040445 |
| 114 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.47943255 |
| 115 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.47465180 |
| 116 | Histidine metabolism_Homo sapiens_hsa00340 | 0.47301445 |
| 117 | Adherens junction_Homo sapiens_hsa04520 | 0.46347614 |
| 118 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.45908793 |
| 119 | Hepatitis B_Homo sapiens_hsa05161 | 0.45726212 |
| 120 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.45570538 |
| 121 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44765901 |
| 122 | Phagosome_Homo sapiens_hsa04145 | 0.44595001 |
| 123 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44590458 |
| 124 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.43500296 |
| 125 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.41984702 |
| 126 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.39300686 |
| 127 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.38701621 |
| 128 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.34135660 |
| 129 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.33717012 |
| 130 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.32694865 |
| 131 | Prostate cancer_Homo sapiens_hsa05215 | 0.29463129 |
| 132 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.29304186 |
| 133 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.28680525 |
| 134 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.28353171 |
| 135 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.26494384 |
| 136 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.25056876 |

